Titlebook: Secondary Prevention in Coronary Artery Disease and Myocardial Infarction; Peter Mathes Book 1985 Martinus Nijhoff Publishers, Dordrecht 1

OPINE

Beta-blocking Agents in the Secondary Prevention after Acute Myocardial Infarction, with Special Ref.6%) in the oxprenolol group (OX) and 45 (5.1%) in the placebo group (PL), the difference being insignificant. Some special features might explain some of the reasons for the ‘negative’ outcome of the study with regard to prevention of sudden coronary death. 275 patients in each group discontinued t

易受刺激

Platelet Aggregation Inhibitorsth when the selection of patients was limited to those with unstable angina (Lewis et al., 1983). Controlled trials of aspirin for the prevention of stroke and of two clinical disorders which commonly precede stroke, namely transient ischaemic attacks and visual disturbances, have also demonstrated

压碎

Platelet Inhibitors or Anticoagulants for Prevention of Aorto-Coronary Bypass Graft OcclusionAcenocoumarol treatment concealed a beneficial effect of T in our patients. In a prospective randomized trial on 148 patients receiving T (250 mg b.i.d.) or anticoagulation by Acenocoumarol from the second or third postoperative day on it was examined, whether T is superior, equal or inferior to ora

Mumble

JAMB

Corroborate

Metabolic Aspects of Preventive Drug Administrationy, as well established the myocardium utilizes free fatty acids and under severe work load mainly lactic acid for substrate supply. Plasma levels of both substrates are markedly increased during work load, due to catecholamine-mediated glycolysis in liver and lactate release from skeletal muscle, wh

使无效